1 Table of Contents2 Introduction
2.1 What Is This Report About?
2.2 Tissue Engineered Skin Substitutes Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Tissue Engineered Skin Substitutes Market, United States
3.1 Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), 2018-2033
3.1.1 Acellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Cellular Skin Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
3.2.1 Acellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Cellular Skin Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Tissue Engineered Skin Substitutes Market, United States, Average Price ($), 2018-2033
3.4 Tissue Engineered Skin Substitutes Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Tissue Engineered Skin Substitutes Market
4.1 Allergan Ltd
4.1.1 Company Overview
4.2 Integra LifeSciences Corp
4.2.1 Company Overview
4.3 MiMedx Group Inc
4.3.1 Company Overview
4.4 Organogenesis Holdings Inc
4.4.1 Company Overview
4.5 Smith & Nephew Plc
4.5.1 Company Overview
4.6 LifeNet Health Inc
4.6.1 Company Overview
6 Recent Developments
6.1 Corporate Communications
6.1.1 Oct 14, 2025: Celularity Publishes Phase 2 Clinical Trial Results on PDA-002 for Diabetic Foot Ulcers
6.1.2 Oct 07, 2025: CureVision Rethinks Wound Healing and Scales with Strategic Partners
6.1.3 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds
6.2 Financial Announcements
6.2.1 Nov 06, 2024: Surrozen Provides Third Quarter 2024 Financial Results and Business Update
6.2.2 Oct 30, 2024: MIMEDX Reports Q3 2024 Operating and Financial Results
6.3 Government and Public Interest
6.3.1 Sep 23, 2025: FibroBiologics To Present At 2025 Cell & Gene Meeting On The Mesa
6.3.2 Aug 28, 2025: Surrozen to Present at Upcoming Healthcare Investor Conference
6.4 Other Significant Developments
6.4.1 Oct 02, 2025: BioStem Technologies Partners with Florida Panthers for 13th Season of 'Heroes Among Us' Program
6.4.2 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds
6.5 Product News
6.5.1 Oct 14, 2025: Celularity Publishes Phase 2 Clinical Trial Results on PDA-002 for Diabetic Foot Ulcers
6.5.2 Oct 13, 2025: BioLargo Subsidiary Clyra Medical Advances Toward Product Launches and Expansion
6.5.3 Oct 01, 2025: CMS Expands Access to RECELL for Patients with Non-Burn Acute Wounds
6.5.4 Sep 30, 2025: Merakris Therapeutics Secures FDA Agreement for Type C Meeting to Discuss MTX-001 Development
6.5.5 Sep 12, 2025: New ICU Study Finds Adhesive Technique Reduces Jugular Line Dressing Failures
6.5.6 Sep 10, 2025: Kane Biotech Completes Enrollment in U.S. Case Series Studies of Its Revyve Antimicrobial Wound Gel and Spray
6.6 Strategy And Business Planning
6.6.1 Oct 13, 2025: BioLargo Subsidiary Clyra Medical Advances Toward Product Launches and Expansion
6.6.2 Oct 07, 2025: CureVision Rethinks Wound Healing and Scales with Strategic Partners
6.6.3 Sep 24, 2025: Alira Health Becomes First Platinum CRO Partner of the Wound Care Collaborative Community
6.6.4 Sep 14, 2025: Avita Medical Receives CE Mark for Recell GO, Enabling Commercialization Across Europe
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 5: Acellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 6: Cellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Table 7: Tissue Engineered Skin Substitutes Market, United States, Average Price ($), 2018-2033
Table 8: Tissue Engineered Skin Substitutes Market, United States, Company Share by Revenue ($m), 2024
Table 9: Tissue Engineered Skin Substitutes Market Pipeline Products
Table 10: Total Number of Primary Research Participants, Wound Care Management Market, by Country
List of Figures
Figure 1: Tissue Engineered Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Acellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cellular Skin Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Tissue Engineered Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 5: Acellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 6: Cellular Skin Substitutes Market, United States, Volume (Units), 2018-2033
Figure 7: Tissue Engineered Skin Substitutes Market, United States, Company Share (%), 2024
